Patents by Inventor Reham M. El-Meligy

Reham M. El-Meligy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170290871
    Abstract: A method of treating hypertension can include administering to a patient in need thereof a therapeutically effective amount of an extract of Matricaria chamomilla L. The extract can be administered orally to the patient in an amount of about 100 mg/kg to about 200 mg/kg.
    Type: Application
    Filed: April 11, 2016
    Publication date: October 12, 2017
    Inventors: AMANI SHAFEEK AWAAD, GHADA MOHAMED ZAIN, REHAM M. EL-MELIGY, AMAL AHMED SAFHI, VIDYA DEVENATHADESIKAN SESHADRI, SHEKHAH SAUD ALMOQREN, NOURAH AHMED AN QURAIN
  • Patent number: 9533019
    Abstract: The Calotropis Procera extracts as anti-ulcerative colitis agents include extracts of Calotropis procera obtained by a method comprising the following steps: (a) providing a plant material derived from Calotropis procera, (b) drying the plant material, (c) pulverizing the plant material to provide a fine powder; and (d) extracting the plant material by percolation using 95% aqueous alcohol in a container to obtain an alcoholic extract. A method of treating ulcerative colitis comprises administering a therapeutically effective amount of an alcoholic extract of C. procera to a patient in need thereof.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: January 3, 2017
    Assignee: KING SAUD UNIVERSITY
    Inventors: Amani Shafeek Awaad, Ghada Mohamed Zain, Reham M. El-Meligy, Haya Fahd Alkanhal, Vidya Devenathadesikan Seshadri
  • Patent number: 9192639
    Abstract: The Convolvulus extract for treating peptic ulcer and Helicobacter pylori infection is an ethanolic extract from C. pilosellifolius. The extract is prepared by homogenizing Convolvulus pilosellifolius aerial plant parts to prepare a powder, percolating the powder with an organic solvent to prepare a suspension, filtering the suspension to obtain a filtrate, and obtaining the extract as a dry powder by drying the solvent under reduced pressure from the filtrate. The active ingredient in the extract is a compound that was isolated from the extract of C. pilosellifolius as a purified triterpene using silica gel column chromatography, the compound being named: 2-propoxyethyl 13-(4-ethoxy-4-oxobutyl)-6b,8a12b,14a-tetramethyl-5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,14a-tetradecahydropicene-2-carboxylate. Both the extract and the isolated active ingredient exhibit anti-ulcerogenic activity, and disk diffusion tests show that various strains of H. pylori are susceptible to both the extract and the active ingredient.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: November 24, 2015
    Assignee: KING SAUD UNIVERSITY
    Inventors: Amani S. Awaad, Asma'a Al-Rifai, Reham M. El-Meligy, Mohamed E. Zain
  • Patent number: 9125912
    Abstract: The method of treating ulcerative colitis includes administering to a patient a therapeutically effective amount of an extract of Ocimum americanum L., Ocimum basilicum, or Ocimum basilicum var. thyrsiflora, to treat the ulcerative colitis in the patient. The extract can be a total alcohol extract, a total phenolic extract, or a volatile oil extract.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: September 8, 2015
    Assignee: KING SAUD UNIVERSITY
    Inventors: Amani Shafeek Awaad, Nouf Al-Morai, Reham M. El-Meligy